Physician profile
Jack L Koch
NPI 1114923737
$1,530.77
in general payments reported to CMS, 2019-2025
15 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.05 · 2020: $35.41 · 2021: $38.99 · 2022: $187 · 2023: $260 · 2024: $328 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $454.83 | 2022-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $199.15 | 2023-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $165.63 | 2021-2025 | Qelbree, Qelbree |
| Janssen Pharmaceuticals, INC | $146.90 | 2024 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $85.38 | 2025 | Caplyta |
| Noven Therapeutics, LLC | $82.18 | 2024-2025 | Xelstrym, Secuado |
| Ironshore Pharmaceuticals INC. | $79.16 | 2019-2023 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $72.89 | 2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $69.12 | 2025 | Auvelity |
| Tris Pharma INC | $67.68 | 2025 | Dyanavel Xr |
| Vanda Pharmaceuticals INC. | $31.58 | 2025 | Fanapt, Hetlioz |
| Abbvie INC. | $24.55 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.85 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.16 | 2025 | Relexxii |
| Jazz Pharmaceuticals INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.